NORTHERN TRUST CORP - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 133 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$5,143,588
+26.7%
296,119
+2.7%
0.00%0.0%
Q2 2023$4,058,941
+29.1%
288,277
-1.3%
0.00%0.0%
Q1 2023$3,143,211
-26.8%
292,120
+1.9%
0.00%0.0%
Q4 2022$4,294,392
+23.2%
286,675
+5.6%
0.00%0.0%
Q3 2022$3,486,000
+30.7%
271,434
-1.4%
0.00%0.0%
Q2 2022$2,667,000
+0.1%
275,305
+2.7%
0.00%
Q1 2022$2,664,000
-19.3%
268,045
-4.5%
0.00%
-100.0%
Q4 2021$3,303,000
+5.6%
280,632
+2.2%
0.00%0.0%
Q3 2021$3,127,000
-21.6%
274,558
-4.1%
0.00%0.0%
Q2 2021$3,986,000
-28.1%
286,198
-4.4%
0.00%0.0%
Q1 2021$5,540,000
+0.2%
299,315
-4.4%
0.00%0.0%
Q4 2020$5,531,000
+14.8%
313,002
-0.4%
0.00%0.0%
Q3 2020$4,817,000
-20.2%
314,412
+32.7%
0.00%0.0%
Q2 2020$6,039,000
+121.5%
237,010
+34.5%
0.00%0.0%
Q1 2020$2,727,000
+66.4%
176,216
+18.9%
0.00%
Q4 2019$1,639,000
+17.8%
148,208
-9.4%
0.00%
Q3 2019$1,391,000
-33.7%
163,513
+5.6%
0.00%
Q2 2019$2,097,000
-12.2%
154,899
+17.1%
0.00%
-100.0%
Q1 2019$2,389,000
+8.2%
132,254
+68.3%
0.00%0.0%
Q4 2018$2,207,000
+9.6%
78,584
-0.5%
0.00%
Q3 2018$2,013,00078,9420.00%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q1 2023
NameSharesValueWeighting ↓
Consonance Capital Management LP 2,374,392$36,376,0004.43%
Opaleye Management Inc. 338,000$8,778,0001.72%
Lion Point Capital, LP 495,748$7,594,0001.67%
Fairmount Funds Management LLC 212,746$3,259,0001.38%
Vivo Capital, LLC 1,151,622$17,643,0001.02%
Spearhead Capital Advisors, LLC 270,117$4,138,0000.79%
Integral Health Asset Management, LLC 120,000$1,838,0000.56%
Endurant Capital Management LP 117,480$1,800,0000.53%
SPHERA FUNDS MANAGEMENT LTD. 259,990$3,983,0000.39%
Ikarian Capital, LLC 342,998$5,254,0000.38%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders